Previous Article in Journal
Evidence of Differences and Discrimination in the Delivery of Care: Colorectal Screening in Healthy People and in the Care and Surveillance of Patients with Inflammatory Bowel Disease
Article Menu

Export Article

Open AccessReview

Asymptomatic Inflammatory Bowel Disease and Colorectal Cancer Screening Programs: How Common Is It and What Should be Done About It?

1
Digestive Diseases Centre, University Hospitals of Leicester, Gwendolen Road, Leicester LE5 4PW, UK
2
Department of Digestive Diseases, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, UK
*
Author to whom correspondence should be addressed.
Gastrointest. Disord. 2019, 1(2), 261-265; https://doi.org/10.3390/gidisord1020021
Received: 24 April 2019 / Revised: 5 May 2019 / Accepted: 16 May 2019 / Published: 17 May 2019
  |  
PDF [217 KB, uploaded 17 May 2019]

Abstract

The growing international popularity of screening programs for the early detection of pre-cancerous changes or early cancer in the colon has brought to the fore the issue of people with asymptomatic inflammatory bowel disease. What are the legal and clinical responsibilities for endoscopists and managers of screening programs towards such patients? This review assesses the magnitude of the problem and discusses the legal responsibilities, including human rights issues. In addition, it discusses whether such patients who do not have symptoms should be given active treatment. View Full-Text
Keywords: inflammatory bowel disease; healthy people; colorectal cancer screening programs; law; human rights inflammatory bowel disease; healthy people; colorectal cancer screening programs; law; human rights
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Farrukh, A.; Mayberry, J.F. Asymptomatic Inflammatory Bowel Disease and Colorectal Cancer Screening Programs: How Common Is It and What Should be Done About It? Gastrointest. Disord. 2019, 1, 261-265.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Gastrointest. Disord. EISSN 2624-5647 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top